washington  reuters    two senior lawmakers on the u s  senate s judiciary committee  on monday pushed for information regarding sharp price increases for epipens  drug filled injectable devices used by people to counter potentially deadly allergic reactions   senator chuck grassley  chairman of the senate judiciary committee  wrote mylan chief executive heather bresch on monday to ask how mylan determined the price of epipens and what changes had been made to the product to account for the higher price  the top democrat on the committee s antitrust subcommittee  senator amy klobuchar  urged the federal trade commission on monday to investigate the prices  citing news reports showing that the price of a pack of two epipens had gone from   in  to   this year  mylan acquired the product in    although the antitrust laws do not prohibit price gouging  regardless of how unseemly it may be  they do prohibit the use of unreasonable restraints of trade to facilitate or protect a price increase   wrote klobuchar  a minnesota democrat who said her daughter relies on an epipen   the ftc should investigate whether mylan pharmaceuticals engaged in activity  such as using incentives or exclusionary contracts with insurers  distributors  or pharmacies  to deny an alternative product access to the market   an epipen injects a pre measured dose of epinephrine  adrenaline  that people use if they are having a dangerous allergic reaction  the ftc did not say whether an investigation was under way   the commission takes seriously its obligation to take action where pharmaceutical companies have violated the antitrust laws   a spokesman said  mylan did not immediately comment on the letters but noted in an email that nearly  percent of people with commercial insurance who use a savings card can get the medicine for free   with changes in the healthcare insurance landscape  an increasing number of people and families are enrolled in high deductible health plans  and deductible amounts continue to rise  this shift has presented new challenges for consumers  and they are bearing more of the cost   mylan also said  the ftc opened a probe into turing pharmaceuticals for possible antitrust violations in connection with the company s decision to sharply raise the price of a life saving drug  turing had raised the price of daraprim to   a tablet from     